BKM120 sensitizes BRCA-proficient triple negative breast cancer cells to olaparib through regulating FOXM1 and Exo1 expression

Yu Li(Shenzhen University Health Science Center), Shuping Wang(China Pharmaceutical University)
Scientific Reports
February 26, 2021
Cited by 44


Related Papers